Sie sind auf Seite 1von 7

K

1. .: act to ensure protection of patient information and half-life


confientiality
2. .: area below the dermis consisting of fatty tissue health insurance
where several medications, such as insulin are injected; subcutaneous portability and
layer accountability act
(HIPAA) filter
3. .: those liquids that contain a combination of alcohol hydoralcoholic
and water
4. .: time at which a medication decreases to half of its hypodermis
original potency

L
1. .: a reimbursement mechanism in which the patient incidental
pays the pharmacy and is later reimbursed by the insurance company disclosure
for a portion of the cost
2. .: inhibiting or decreasing the effect of a process; indemnification
antagonist
3. .: injectable medication that is administered indication
intravenously (into the vein)
4. .: injections employing small volumes of fluid that inducer
are delivered deep into muscle tissue by relatively longer and larger-
bore needles
5. .: personal information is shard unintentionally with inhibitor
unauthorized users during the performance of daily operations
6. .: pressure in the eye that is elevated in disorders, intramuscular (IM)
such as glaucoma
7. .: stimulating or increasing the effect of a process; intraocular pressure
agonist (IOP)
8. .: what a medication is used for intravenous (IV)

M
1. .: compounded sterile preparation prepared by IV admixture
adding medication to an IV bag
2. .: intravenous preparation administered at a ketoacidosis
constant drip rate along with a large volume parenteral such as normal
saine or dextrose usually through a Y-site connector port

3. .: intravenous preparation adminsitered over hours IV infusion


to days at a constant drip rate
4. .: medications given intravenously over a short IV piggyback (IVPB)
period of time

5. .: metabolic complication primarily in Type-I IV push/IV bolus


diabetes in which the body breaks down fat instead of carbohydrates
for energy often due to a lack of insulin in the body

N
1. .: the body movements we make using head, face, ketoacidosismetabolic
arms, and legs when communicating with a patient
2. .: metabolic complication primarily in Type-I kinesics
diabetes in which the body breaks down fat instead of carbohydrates
for energy often due to a lack of insulin in the body

O
1. .: a number that identifies medications as belonging lactic acidosis
to particular batches produced by the manufacturer; "control number"
2. .: although similar to cream, this dosage form lactose intolerance
contains more liquid and is applied more easily over larger areas of the
body
3. .: disorder in which one is unable to digest dairy laminar-flow hood
products containing lactose resulting is abdominal bloating and (horizontal)
flatulence
4. .: facility where patients reside and are cared for by laminar-flow hood
trained personnel for an extended period of time; "nursing home" or (vertical)
"skilled nursing facility"
5. .: has the HEPA filter perpendicular to the work laxative
surface; the clean air blows from the filter toward the person working
in the hood, thereby keeping particulate matter away from the work
surface
6. .: HEPA filter is parallel to the work surface and least amount
clean air blows straight down toward the work surface; protects the weighable
person (LAW)/least
weighable quantity
(LWQ)
7. .: life-threatening metabolic complication legend statement
characterized by muscle pain, weakness, shortness of breath,
dizziness, and bradycardia in which there is a buildup of lactic acid
often due to a lack of oxygen
8. .: medication used to relieve constipation, rectify levigation
incomplete or irregular bowel movements, or evacuate the bowel
9. .: medications that can be dispensed only by libido
prescription have either a "Rx-only" symbol or the following statement
on their labels "Cation: federal law prohibits dispensing without
prescription"; prescription-only medication
10. .: mixing technique in which two substances are liniment
mixed together on an ointment slab using a spatula to reduce the
particle size
11. .: mixture of various substances in oil, alcoholic long-term fare
solutions of soap, or emulsions intended for external application; often facility (LTCF)
used for their heat-producting effects
12. .: pharmaceutical used to treat or manage chronic lotion
long-term conditions and illnesses

13. .: sex drive lot number


14. .: the least amount that may be weighed on a class A maintenance
balance; preparations below this amount may be made in batch medication
preparations or by using aliquots

P
1. .: insurance plans administered by states for the managed care
"medically needy" organization (MCO)
2. .: physician, usually an allopathic physician (as maximum allowable
opposed to an osteopathic physician) cost (MAC)
3. .: the surface of a liquid in which surface tension MD
causes the liquid to cling to the sides of a container; when measuring
liquids in a graduated cylinder, one should measure from the bottom of
the this
4. .: a bowl-like material used in compounding medicaid
primarily non-steril preparations
5. .: a drug product that is available from more than medicare
one manufacturer
6. .: an organization designed to manage the cost and medicare part D
quality of and access to health care services
7. .: far vision; far sightedness meniscus
8. .: insurance plans administered by the government mortar
primarily for individuals over 65 years of age and people with
disabilities
9. .: near vision; near sightedness multiple-source
drug
10. .: prescription medication insurance plan mydriasis
administered by the government primarily for individuals over 65 years
of age and people with disabilities
11. .: the maximum amount that will be paid by a third- myosis
party payer for a multiple-source medication;

Q
1. .: nurse practitioner NDC Number
(National Drug
Code)
2. .: practice adequate notice of how a covered notice of privacy
entity may use and disclose protected health information about
the individual, as well as his or her rights and the covered entity's
obligations with respect to that information
3. .: this is assigned by the manufacturer and NP
placed on all prescription stock packages; identifies the
manufacturer, the actual chemical entity, and the package size

R
1. .: a greasy preparation, usually prepared with a OD
petroleum jelly base, which is used to deliver medication to areas
of the skin that need protection; leaves oily coatings on the skin
2. .: a network of pharmacies organized by a MCO ointment
or PBM in which all community pharmacies are invited to sign
participating pharmacy agreements
3. .: a federal law that increases pharmacists' Omnibus Budget
professional responsibilities by requiring them to keep records, to Reconciliation
perform prospective drug utilization review, and to offer to Act of 1990
counsel patients about the proper use of their medications (OBRA '90)
4. .: a sterile medication for the eye that may be in open-ended
the form of drops or ointments question
5. .: a sudden decrease in blood pressure upon open panel
standing defined as a drop of 20 mmHg or more in systolic blood
pressure or a drop of 10 mmHg or more in diastolic blood
pressure; puts patents at risk for injury due to fainting
6. .: medication of the ear that is usually supplied ophthalmic
in dropper bottles overfill technique used in compounding in preparation
which products are compounded for more than the originally-
prescribed amount (e.g. 10% more) to compensate for loss due to
compounding
7. .: medications considered to be safe to take or orthostatic
use without a prescription; typically stocked outside of the hypotension
pharmacy department
8. .: optometrist otic preparation

9. .: question eliciting a longer response often in over-the-counter


the form of "who," "what," "where," and "why" questions (OTC)

S
1. .: a privilege granted to an inventor that allows PA
exclusive or sole rights to market a product or device for a limited
period of time
2. .: an organization that specializes in the parenteral
management of the prescription portion of a managed health care
plan; this contracts with participating pharmacies, process claims,
control costs, and manage the various elements of the pharmacy
benefit including formularies and utilization review
3. .: contains just enough fluid volume to safely parenteral (small-
deliver the medication into a patient's veins volume)
4. .: contract between the pharmacy and the third- parenteral (large-
party payer that specifies program features such as dispensing fee volume))
and the method of determining drug acquisition cost
5. .: device in which pain medication is delivered at participating
a rate determined by the patient being treated; built-in controls pharmacy
prevent the patient from overdosing agreement
6. .: literally means "outside of the gastrointestinal patent
tract"; describe any medication given by a route of administration
other than oral or rectal, it's usually used to describe injectable
medications
7. .: medication, often in the form of shampoo, that patient-controlled
kills lice analgesia (PCA)
device
8. .: medications that have the same active patient cost
ingredients, same dosage form, same route of administration, sharing
same strength
9. .: mixing instrument used to crush tablets and patient profile
mix substances in a mortar
10. .: patient record that is kept in the pharmacy pediculicide
department
11. .: physician assistant pestle
12. .: portion of a prescription expense which is paid pharmaceutical
out of pocket by the patient; three most common forms are equivalence
deductibles, copayments, coinsurance
13. .: study of what drugs do to the body pharmacy benefit
manager (PBM)
14. .: study of what the body does to drugs pharmacodynami
cs
15. .: used when the fluid itself is the treatment pharmacokinetics
(e.g.TPN/prevent or treat dehydration)

T
1. .: is a Latin abbreviation that means "as pharmacology
needed"; these refills are prescription medications that are
usually allowed for a max. of 1 year
2. .: a group of hospitals, physicians, and pharynx
pharmacists that contracts with employers, insurance carriers,
and third-party administrators to provide medical services for
negotiated fees; patients are given cost incentives (e..g owed
patient cost-sharing requirements) to sue the network of
"preferred providers" for services
3. .: a requirement that specific medications be point of scale
covered only if approved by the third-party payer; usually (POS)
prescribers or pharmacists have to certify that the medication is
medically necessary and superior to less costly alternatives
before approval is given o dispense it
4. .: a response to public concern over potential power of hydrogen
abuses of the privacy of health information that establishes a (pH)
category of health information, referred to as protected health
information, which may be used or disclosed to others in certain
circumstances or under certain conditions
5. .: distance between you and the patient while precaution
communicating
6. .: information similar to warnings, but not as preferred provider
severe organization (PPO)
7. .: label that is affixed to the actual prescription prescription
order form; these are used to file and track prescriptions within container label
the pharmacy department
8. .: label that is affixed to the medication prescription
container that is given to the patient; includes patient-specific information label
and medication-related information
9. .: measure of how acidic or basic a substance is; prior
blood pH is 7.4 authorization
10. .: person who assures compliance with HIPAA privacy officer
and all other federal and state rules and regulations pertaining to
the use and release of PHI
11. .: personal, identifiable information about privacy rule
individuals which is created or received by a health plan,
provider, or health care clearinghouse
12. .: study of medications including their PRN refill
composition, indications, adverse effects, and how they act in the
body
13. .: system computer technology linking protected health
pharmacies and third-party payers through telephone lines information
allowing eligibility verification, claims submission, claims
adjudication, and utilization review at the time the prescriptions
are dispensed
14. .: throat proxemics

U
1. .: a classification of controlled substances schedule I (C I)
which includes drugs that have a high potential for abuse; no
currently accepted medical use in U.S. and are unsafe for use
under medical supervision; not found in pharmacy departments
2. .: classification of controlled substances which Schedule II (C II))
includes medications that has a currently accepted medical use
in the U.S. and a high potential for abuse and physical or
psychological dependence; examples include morphine (narcotic),
methamphetamine (stimulant) and secobarbital (depressant)
3. .: classification of controlled substances which schedule III (C III)
includes medications that have an abuse potential less than that
of medications listed in I and II; abuse of these meds may lead to
moderate or low physical dependence or high psychological
dependence; (e.g. tylenol w/ codeine #3); certain stimulants or
depressants
http://quizlet.com/12954687/pharmacy-vocabulary-flash-cards/

Das könnte Ihnen auch gefallen